U.S. Marine and Shipping Stock News

NYSE:FLS
NYSE:FLSMachinery

Flowserve’s Addition of Duke Energy CFO Savoy Raises a Deeper Question About FLS’s Energy Transition Strategy

On March 16, 2026, Flowserve Corporation increased its board size from ten to eleven directors and appointed Duke Energy CFO Brian Savoy to its Board, Audit Committee, and Technology, Innovation and Risk Committee. Savoy’s deep experience in finance, strategy, and energy-sector transformation brings additional oversight and domain expertise to Flowserve as it advances its flow management and digital solutions focus. Next, we’ll examine how adding Brian Savoy to the board could influence...
NasdaqGS:XEL
NasdaqGS:XELElectric Utilities

Is It Time To Reassess Xcel Energy (XEL) After Recent Share Price Pullback?

If you are looking at Xcel Energy and wondering whether the current share price offers value or risk, this article breaks down what the numbers are actually saying about the stock. Xcel Energy recently closed at US$78.09, with returns of 1.7% over 7 days, a 6.5% decline over 30 days, 4.6% year to date, 15.5% over 1 year, 28.3% over 3 years and 37.0% over 5 years. These moves have caught the attention of investors watching for changing expectations. Recent coverage of Xcel Energy has focused...
NasdaqGS:DSGR
NasdaqGS:DSGRTrade Distributors

Is It Time To Reassess Distribution Solutions Group (DSGR) After The US$29.50 Go Private Proposal

How Distribution Solutions Group's recent share price sets up a valuation check Before getting into detailed valuation work, it helps to understand how Distribution Solutions Group's share price has been behaving and what recent information is shaping expectations. Over the last week, the stock has been relatively steady with a 0.2% decline, but the past month has seen a sharper 12.6% pullback and the year to date return sits at a 7.2% loss, with the last 12 months at a 6.8% loss, even though...
NYSE:SCCO
NYSE:SCCOMetals and Mining

Southern Copper (SCCO) Valuation Check After Sharp Monthly Pullback And Long Term Rally

Why Southern Copper is on investors’ radar today Southern Copper (SCCO) has drawn attention after recent trading left the stock with a 1 day return of 1.4% and a past month move of about a 25% decline, sharpening focus on its valuation. See our latest analysis for Southern Copper. The recent pullback in Southern Copper’s share price, with a 30 day return of about a 25% decline, contrasts with its 1 year total shareholder return of 83.6%. This suggests longer term momentum, while short term...
NasdaqGS:FBNC
NasdaqGS:FBNCBanks

A Look At First Bancorp (FBNC) Valuation As P/E And DCF Send Mixed Signals

First Bancorp (FBNC) has drawn fresh attention after recent share price moves, with the stock now trading at US$55.19. That price corresponds to a year total return of 39.5% for investors. See our latest analysis for First Bancorp. The recent pullback, with a 1-month share price return of an 8.34% decline, sits against a stronger backdrop of an 8.41% year to date share price return and a 39.55% 1-year total shareholder return. This suggests momentum has cooled, but long-term holders have...
NYSE:MAN
NYSE:MANProfessional Services

Is ManpowerGroup’s (MAN) AI Talent Push Reframing Its Earnings-First Investment Story?

Earlier this year, ManpowerGroup reported quarterly revenue growth of 7.1% year on year, beating analyst expectations but missing EPS estimates, while highlighting progress in cost optimization, technology initiatives, and a disciplined transformation plan amid gradually stabilizing market trends. A separate initiative, the 2026 VivaTech Startup Challenge, underscores how ManpowerGroup is using AI to address talent shortages, with its latest survey showing employer demand for AI capabilities...
NYSE:QBTS
NYSE:QBTSSoftware

D Wave Quantum Podcast Sheds Light On Real World Demand And Valuation

D-Wave Quantum (NYSE:QBTS) announced a new interview podcast series, "Quantum Matters". The series will highlight real world quantum applications across industries such as manufacturing, supply chain, aerospace, life sciences and AI. The podcast will feature conversations with sector leaders focused on practical use cases for quantum computing. D-Wave Quantum operates in the quantum computing space, with a focus on practical problem solving for businesses rather than purely academic...
NasdaqCM:RGTI
NasdaqCM:RGTISemiconductor

Rigetti Board Exit Puts Focus On Governance Risks And Share Price Upside

Rigetti Computing board member H. Gail Sandford has informed the company that she will not stand for re election at the upcoming annual meeting. The company has stated that Sandford’s decision is not due to any disagreement with Rigetti Computing on operations, policies, or practices. Her departure will create a vacancy on the board, which may be filled through future director appointments or changes in committee roles. For investors tracking NasdaqCM:RGTI, this board change comes at a time...
NasdaqGS:LGN
NasdaqGS:LGNConstruction

Legence (LGN) Q3 Revenue Strength Tests Bullish Narratives On Path To Profitability

Legence (LGN) has just posted another busy quarter, with Q3 FY 2025 revenue of US$708.0 million and a small loss, as Basic EPS landed at a US$0.02 loss and net income excluding extra items was a US$1.1 million loss. The company has seen revenue move from US$560.8 million in Q3 FY 2024 to US$708.0 million in Q3 FY 2025. Over the trailing 12 months, revenue reached about US$2.4 billion against a trailing 12 month net loss of US$19.8 million, putting the spotlight squarely on scaling margins...
NasdaqGM:GPCR
NasdaqGM:GPCRPharmaceuticals

Structure Therapeutics Obesity Trial Success Puts Valuation Gap In Focus

Structure Therapeutics (NasdaqGM:GPCR) released highly positive Phase 2 topline data for its oral GLP-1 receptor agonist aleniglipron in obesity and overweight patients. The new results from the ACCESS clinical program show significant weight loss, a compelling safety and tolerability profile, and low discontinuation rates. The company plans to advance aleniglipron into Phase 3 trials based on these Phase 2 outcomes. Structure Therapeutics focuses on small molecule medicines, and...
NYSE:BROS
NYSE:BROSHospitality

Is It Time To Reassess Dutch Bros (BROS) After Recent Share Price Pullback?

Wondering whether Dutch Bros at around US$46.69 still makes sense for your portfolio, or if the price now bakes in too much optimism. The stock has had a mixed run, with a 6.6% decline over the last week, an 8.2% decline over the past month, a 24.9% decline year to date, yet a 47.6% return over three years. Recent coverage has focused on how Dutch Bros fits into the broader consumer services space and how sentiment toward growth oriented concepts has shifted over time. This context helps...
NasdaqGS:CSX
NasdaqGS:CSXTransportation

Is CSX’s Locomotive Upgrades and Maine Branch Revival Altering The Investment Case For CSX (CSX)?

Earlier this year, CSX announced a US$670 million agreement with Wabtec to upgrade its locomotive fleet with modern Evolution Series units, while partner TransloadX moved to revive two largely dormant Maine branch lines leased from CSX to support regional industrial rail activity. Together, these steps point to CSX pairing long-term efficiency upgrades in its core network with efforts to reactivate underused rail corridors through third-party investment. Next, we’ll examine how CSX’s US$670...
NYSE:DLB
NYSE:DLBSoftware

Is Dolby Laboratories (DLB) Offering Value After Recent Share Price Pullback

If you are wondering whether Dolby Laboratories at around US$58 per share offers value or a value trap, the starting point is understanding what the current price actually bakes in. The stock has recently pulled back, with returns of 3.8% over 7 days, 9.7% over 30 days and 8.7% year to date, adding to a 25.9% return over 1 year, 28.6% over 3 years and 38.8% over 5 years. Recent coverage around Dolby has focused on its position in audio and visual technologies and how it fits into broader...
NYSE:TGT
NYSE:TGTConsumer Retailing

Is It Time To Reconsider Target (TGT) After Its Recent Share Price Recovery?

If you are asking whether Target is priced fairly today, the starting point is understanding how the current share price lines up with different measures of value. The stock closed at US$119.84, with returns of 5.8% over 7 days, 2.9% over 30 days, 19.2% year to date, 20.9% over 1 year, and declines of 19.4% over 3 years and 31.0% over 5 years. Taken together, this gives you a mixed picture of both recent momentum and longer term risk. These moves sit against a backdrop where investors have...
NYSE:TTI
NYSE:TTIEnergy Services

Assessing TETRA Technologies (TTI) Valuation After Mixed Recent Share Performance

Recent performance and what it might mean for TETRA Technologies (TTI) TETRA Technologies (TTI) has seen mixed share performance recently, with a 2.6% gain over the past day and 8.3% over the past week, compared with a decline of 22.6% over the past month and a 7.7% decline over the past three months. See our latest analysis for TETRA Technologies. Looking past the latest bounce, the 30 day share price return of negative 22.6% and year to date share price return of negative 11.95% sit against...
NasdaqGS:MDGL
NasdaqGS:MDGLBiotechs

A Look At Madrigal Pharmaceuticals (MDGL) Valuation After Recent Share Price Strength And Updated Fair Value Estimate

Event driven snapshot of Madrigal Pharmaceuticals Madrigal Pharmaceuticals (MDGL) has drawn investor attention after recent share price moves, including a 1 day return of about 2% and a 16% gain over the past week, against mixed month and past 3 months performance. See our latest analysis for Madrigal Pharmaceuticals. The recent 15.8% 7 day share price return contrasts with a weaker year to date share price performance and a much stronger 1 year total shareholder return of 55.8%. This...
NasdaqGM:ZNTL
NasdaqGM:ZNTLBiotechs

Zentalis Pharmaceuticals (ZNTL) Posts Zero Revenue Challenging Bullish Revenue Recovery Narratives

Zentalis Pharmaceuticals (ZNTL) has just posted its FY 2025 first half results with total revenue at US$0 million, basic EPS at a loss of US$1.05, and net income excluding extraordinary items at a loss of US$75.2 million. This puts the focus firmly on expense control and cash burn. Over the recent periods, the company has seen revenue move from US$40.6 million in the first half of 2024 to US$26.9 million in the second half of 2024, before dropping to zero in the latest half. Half year basic...
NYSE:NWN
NYSE:NWNGas Utilities

Is It Too Late To Consider Northwest Natural Holding (NWN) After A 30% One-Year Rally?

Wondering if Northwest Natural Holding at US$52.83 is priced attractively or already reflects most of its potential? This article walks through the numbers so you can judge the valuation for yourself. The stock has returned 2.7% over the last 7 days, 5.7% over 30 days, 13.0% year to date and 29.6% over 1 year, with 3-year and 5-year returns of 27.9% and 23.9% respectively. These returns naturally raise questions about what is now baked into the price. Recent coverage has focused on how gas...
NasdaqGS:SFM
NasdaqGS:SFMConsumer Retailing

Is Sprouts (SFM) Using Premium Pet Nutrition To Quietly Reinforce Its Health-Focused Brand Edge?

Get Joy, a functional gut-healthy dog nutrition company, has already rolled out its Freeze Dried Raw Chicken and Beef Meals into more than 360 Sprouts Farmers Market stores nationwide, following its nationwide launch that began on April 6. This expansion broadens Sprouts’ better-for-you pet assortment, aligning its pet aisles with wellness trends that increasingly mirror how customers shop for their own nutrition. Next, we’ll explore how adding Get Joy’s gut-focused dog meals could influence...
NYSE:JBS
NYSE:JBSFood

JBS Index Removal Puts Focus On Valuation Momentum And Dividend Risks

JBS (NYSE:JBS) has been removed from the FTSE All-World Index. The change affects the company’s presence in a major global equity benchmark tracked by many passive funds. The decision may influence how both current and prospective shareholders assess JBS within global portfolios. JBS, trading at $17.03, has seen a return of 19.5% over the past week and 20.1% year to date, with a 3.8% return over the past 30 days. With a value score of 6, the stock sits in a segment of the market that some...
NasdaqGS:ACGL
NasdaqGS:ACGLInsurance

Is Arch Capital Group (ACGL) Still Attractive After Recent Share Price Softness?

Wondering whether Arch Capital Group at around US$93 per share still offers value, or if most of the opportunity is already reflected in the price? This article focuses squarely on what the current valuation signals might be telling you. The stock has gained 1.2% over the last 7 days, while showing a 6.0% decline over 30 days and a slight 0.5% decline year to date, alongside a 1.7% decline over the last year and longer term returns of 44.8% over 3 years and 149.3% over 5 years. Recent...
NYSE:HLT
NYSE:HLTHospitality

A Look At Hilton (HLT) Valuation After Earnings And Guidance Surpassed Forecasts

Hilton Worldwide Holdings (HLT) has drawn fresh investor attention after reporting a quarter where revenue came in 3.3% above analyst expectations and EBITDA guidance for the next quarter also exceeded forecasts. Even with these earnings and guidance beats highlighting Hilton’s position within the consumer discretionary travel and vacation providers sector, the stock has moved lower since the release. This has raised questions about how the market is reading the update. See our latest...
NYSE:CL
NYSE:CLHousehold Products

Is Colgate Palmolive (CL) Offering Value After Recent Share Price Weakness?

If you are wondering whether Colgate-Palmolive at around US$84.29 is offering fair value or hiding a discount, this breakdown is designed to help you frame that question clearly. The share price has slipped around 1.0% over the last week and 12.8% over the last month, even though the year to date return is 8.5% and the 1 year return sits at 7.0% in decline, with 3 year and 5 year returns of 20.4% and 20.8% respectively. Recent attention on Colgate-Palmolive has centered on how the stock fits...
NYSE:DEC
NYSE:DECOil and Gas

A Look At Diversified Energy’s Valuation After Its Recent Share Price Rebound

Recent performance snapshot Diversified Energy (DEC) has attracted fresh attention after a strong recent share price move, with the stock showing double digit gains over the past week, month and past 3 months. See our latest analysis for Diversified Energy. The recent surge in DEC's share price, with a 39.05% 1 month share price return and 22.70% year to date share price return, sits against a 44.68% 1 year total shareholder return but weaker 3 and 5 year total shareholder returns. This...